While the beneficial phenotype is peripheral-driven and likely due to a sub-optimal recombination efficiency of the inducible genetic model, the finding of this study raises a key question for future investigation as to whether the CNS-expressing SPL or S1P plays a role in the progression of EAE as well as MS. The gene discussed is MBTPS1; the disease is myeloid sarcoma.